Access Pharmaceuticals awarded patent for MuGard Access Pharmaceuticals has received notification from the European Patent Office that an additional European patent for MuGard has been granted. The patent protects a wide range of liquid formulations for the prevention and treatment of mucosal diseases and disorders. Notification of the grant was published in the European Patent Bulletin no. 13/36 earlier this month.
News For ACCP From The Last 14 Days
Check below for free stories on ACCP the last two weeks.